Analgesia Clinical Trial
Official title:
The Effect of the Popliteal Plexus Block on Postoperative Opioid Consumption, Pain, Muscle Strength and Mobilization After Total Knee Arthroplasty - a Randomized, Controlled, Blinded Study
Verified date | November 2023 |
Source | Regionshospitalet Silkeborg |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In this study we wish to investigate the analgesic effect 3 different nerve block regimes in patients following primary total knee arthroplasty (TKA). All nerve blocks were performed as single shot blocks with the administration of Marcain 5 mg/ml. Regime A: proximal Femoral Triangle Block (FTB) with 10 ml including Intermediate Femoral Cutaneous Nerve Block (IFCNB) with 5 ml + Popliteal Plexus Block (PPB) with 10 ml. Regime B: proximal FTB with 10 ml including IFCNB with 5 ml. Regime C: Adductor Canal Block (ACB) with 25 ml.
Status | Completed |
Enrollment | 165 |
Est. completion date | June 26, 2023 |
Est. primary completion date | June 26, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years and older |
Eligibility | Inclusion Criteria: - Scheduled to undergo primary total knee arthroplasty in spinal anesthesia - Able to perform a Timed Up and Go (TUG) test - Age > 50 years old - Ability to give their written informed consent to participating in the study after having fully understood the contents of the study - American Society of Anesthesiologists (ASA) physical status 1, 2, or 3 Exclusion Criteria: - Patients who cannot cooperate - Patients who cannot understand or speak Danish. - Patients with allergy or intolerance to the medicines used in the study - Patients with a daily intake of strong opioids (morphine, oxycodone, ketobemidone, methadone, fentanyl) - Patients suffering from alcohol and/or drug abuse - based on the investigator's assessment - BMI > 40 - Diagnosed with chronic central or peripheral neurodegenerative disorders |
Country | Name | City | State |
---|---|---|---|
Denmark | Johan Kløvgaard Sørensen | Skanderborg |
Lead Sponsor | Collaborator |
---|---|
Regionshospitalet Silkeborg |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Total opioid consumption in each group, A, B and C | Total opioid consumption is the aggregate of the opioid administered by the Patient Controlled Analgesia (PCA) pump and any potential rescue opioids administered, calculated as IV morphine equivalents | from time of skin closure (end of surgery) until 24 hours postoperative | |
Secondary | Total opioid consumption in each group, A, B and C | Total opioid consumption is the aggregate of the opioid administered by the PCA pump and any potential rescue opioids administered, calculated as IV morphine equivalents | from time of skin closure (end of surgery) until 12 hours postoperative | |
Secondary | Post-block Maximum Voluntary Isometric Contraction (MVIC) by knee extension, calculated as a percentage of the Pre-block baseline value | Both MVIC test are assessed preoperative, using a handheld dynamometer | A 60 minutes interval is between pre-block and post-block MVIC assessments | |
Secondary | Post-block MVIC by ankle plantarflexion, calculated as a percentage of the Pre-block baseline value | Both MVIC test are assessed preoperative, using a handheld dynamometer | A 60 minutes interval is between pre-block and post-block MVIC assessments | |
Secondary | Post-block MVIC by ankle dorsiflexion, calculated as a percentage of the Pre-block baseline value | Both MVIC test are assessed preoperative, using a handheld dynamometer | A 60 minutes interval is between pre-block and post-block MVIC assessments | |
Secondary | Muscle strength of knee extension, graded by Manual Muscle Test (MMT) | Grade 3: Able to extend the knee in active Range of Motion (ROM) against gravity, Grade 2: Patient is lying on the side, with knee resting on the bed, able to extend the knee in active ROM with minimal assistance from the investigator, Grade 1: Muscle contraction of the quadriceps muscle is palpable or observable but the knee does not extend, Grade 0: No muscle contraction of the quadriceps muscle is palpable or observable | Assessed pre-block, post-block (60 minutes after pre-block) and postoperative 5 hours after time of skin closure (end of surgery) | |
Secondary | Muscle strength of ankle plantarflexion, graded by MMT | Grade 3: Able to plantarflex in active ROM, Grade 2: Patient is lying on the side, with ankle resting on the bed, able to plantarflex the ankle in active ROM with minimal assistance from the investigator, Grade 1: Muscle contraction of the gastrocnemius muscle is palpable or observable but the ankle does not plantarflex, Grade 0: No muscle contraction of the gastrocnemius muscle is palpable or observable | Assessed pre-block, post-block (60 minutes after pre-block) and postoperative 5 hours after time of skin closure (end of surgery) | |
Secondary | Muscle strength of ankle dorsiflexion, graded by MMT | Grade 3: Able to dorsiflex in active ROM Grade 2: Patient is lying on the side, with ankle resting on the bed, able to dorsiflex the ankle in active ROM with minimal assistance from the investigator, Grade 1: Muscle contraction of the tibialis anterior muscle is palpable or observable but the ankle does not dorsiflex, Grade 0: No muscle contraction of the tibialis anterior muscle is palpable or observable | Assessed pre-block, post-block (60 minutes after pre-block) and postoperative 5 hours after time of skin closure (end of surgery) | |
Secondary | Timed Up and Go (TUG) test postoperative | Measure of seconds it takes a patient to get up from a chair with armrest, walk a distance of three meters, turn around, walk back and sit down again. All patients must use crutches for the test. If patient cannot mobilize with crutches, the test will not be performed. | Assessed 5 hours after time of skin closure (end of surgery) | |
Secondary | Worst pain during TUG | Patient will be asked to indicate worst pain, Numeric Rating Scale (NRS), 0-10, experienced during the TUG test | Assessed at the end og the TUG test, 5 hours after time of skin closure (end of surgery) | |
Secondary | Pain at rest | Patient will be asked to indicate pain intensity at rest (NRS, 0-10) | preoperative (preblock baseline), 2, 5 (prior to TUG test), 7, 20 and 24 hours after time of skin closure (end of surgery) | |
Secondary | Pain during 90 degrees active flexion of the knee | Patient will be asked to indicate worst pain intensity during active flexion of the knee towards 90 degrees (NRS, 0-10) | preoperative (preblock baseline), 2, 5 (prior to TUG test), 7, 20 and 24 hours after time of skin closure (end of surgery) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05534230 -
Dexmedetomidine for Pain Reduction in CABG
|
N/A | |
Recruiting |
NCT06275698 -
HONEY for the Treatment of POst-Tonsillectomy Pain
|
N/A | |
Recruiting |
NCT04436224 -
Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation
|
Phase 4 | |
Not yet recruiting |
NCT04548323 -
Hypoalgesic Effects of Walking and Running Imagined
|
||
Completed |
NCT06054945 -
Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
|
||
Completed |
NCT04394481 -
Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery
|
Phase 4 | |
Completed |
NCT04690647 -
The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement.
|
N/A | |
Completed |
NCT05034601 -
ESPB vs TPVB for Postoperative Analgesia After the Nuss Procedure
|
N/A | |
Completed |
NCT03740815 -
Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection
|
N/A | |
Recruiting |
NCT05454202 -
Assessment of the Interest of ANI in the Non-communicating Patient in Palliative Care
|
||
Recruiting |
NCT04554186 -
Serratus Anterior Plane Block Versus Thoracic Paravertebral Block.
|
N/A | |
Not yet recruiting |
NCT06393777 -
Effectiveness of Pre-administered Natural Sweet-tasting Solution (Honey) for Decreasing Pain of Needle Insertion
|
N/A | |
Suspended |
NCT04860635 -
Safety of F14 Following Total Knee Replacement
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT04519463 -
The Effect of Local Anesthesia With Lidocaine During Insertion and Removal of Nasal Packing
|
Early Phase 1 | |
Completed |
NCT02916342 -
Interscalene Block Versus Combined Supraprascapular: Axillary Nerve Blocks
|
Phase 4 | |
Completed |
NCT03206554 -
Local Infiltration Analgesia in Total Knee Arthroplasty
|
Phase 2 | |
Not yet recruiting |
NCT02549118 -
Tenoxicam for Intrapartum Analgesia
|
Phase 2 | |
Not yet recruiting |
NCT02190760 -
Comparison Between Perineural and Systemic Effect of Dexamethasone for Interscalene Brachial Plexus Block.
|
N/A | |
Completed |
NCT01789606 -
Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet
|
Phase 3 | |
Completed |
NCT01299584 -
ULTIVA Post Marketing Surveillance
|
N/A |